Evidence map›Paper›PMID 35512294›Full record

ArticleILAR journal2021

Fit for Purpose Assessment: A New Direction for IACUCs.

Lewis B Kinter, David K Johnson, Robert H Weichbrod, Ernest D Prentice, Richard C Simmonds, Paul W Houghton, Robert A Whitney, Joseph DeGeorge, W Ron DeHaven, Klaas Kramer and 1 more

Open access · greenAbstract read
In one paragraph

Article in ILAR journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Lewis B KinterPresident and Principal Scientist, GLP Scientific Consulting LLC, Unionville, Pennsylvania, USA.
David K JohnsonPresident of Cascades Biosciences, Sisters, Oregon, USA.
Robert H WeichbrodAnimal Program Administrator (retired), National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.
Ernest D PrenticeProfessor Emeritus, Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Richard C SimmondsProfessor Emeritus, University of Nevada, Reno, Nevada, USA.
Paul W HoughtonPrimatologist and Principal, Primate Products, Inc, Immokalee, Florida, USA.
Robert A WhitneyFormer Director of The National Center of Research Resources (NCRR), NIH, Bethesda, MD and former Chair of the US Government Interagency Research Animal Committee (IRAC), Bethesda, Maryland, USA.
Joseph DeGeorgePrincipal and Managing Partner, Bianca Holdings, LLC, Lansdale, Pennsylvania, USA.
W Ron DeHavenPresident, DeHaven Veterinary Solutions, LLC, El Dorado Hills, California, USA.
Klaas KramerLaboratory Animal Welfare Officer (retired), VU University Amsterdam, the Netherlands.
Louis DeTollaFounding Director of the Comparative Medicine Program (retired), University of Maryland, Baltimore, Maryland, USA.
Cascade (United States) · USNational Eye Institute · USPrimate Conservation · USScientific Consulting Group · USUniversity of Maryland, Baltimore · USUniversity of Nebraska Medical Center · USUniversity of Nevada, Reno · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The organization and function of the institutional animal care and use committee (IACUC) is the key component of government regulation and oversight of necessary scientific research using live animals and of AAALAC - International accreditation of animal care and use programs in the United States. The regulations, roles, and responsibilities of IACUCs have evolved since their inception 35 years ago from a limited focus on animal welfare and specific animal procedures to embracing scientific quality, data reproducibility and translation, and animal welfare as inextricably interdependent and critical components of generation of new scientific knowledge and medical treatments. A current challenge for IACUCs is in evaluating whether benefits to be derived (eg, new knowledge or treatments) justify any unavoidable pain, stress, or injury associated with proposed research protocols, because the former are long-term and at best speculative outcomes, whereas the latter are immediate and tangible for the study animals. Scientific consensus is that research most likely to generate significant new knowledge and medical treatments is that conducted to high scientific, technical, and quality standards and reported with full transparency to facilitate reproducibility. As an alternative to current benefits evaluations included in risk benefit and harm benefit constructs, the authors propose that IACUCs assess the proposed research for scientific quality and alignment of study elements with the study purpose (e.g., Fit for Purpose [FfP]), including justifications for study design components, selection of primary endpoints and technologies, rationale for data and statistical analyses, and research communication plans. Fit for Purpose endpoints are objective, immediate, and impactful as are the potential risks for study animals, and at the same time they are the best predictors for achievement of longer-term benefits. We propose that IACUCs and any revision of The ILAR Guide consider FfP concepts in place of traditional benefits assessment to accelerate the generation of new knowledge and treatments benefiting medical and veterinary patients and the environment through better science and animal welfare rather than to continue to rely on speculative future outcomes.

Indexed as

Animal Care CommitteesAnimalsAnimal WelfareReproducibility of ResultsUnited Statesfit-for-purpose assessmentharm-benefit analysisinstitutional animal care and use committeerisk–benefit analysis

Identifiers

PMID35512294
PMCPMC10091468
OpenAlexW4225503317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.